2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Jasvinder A. Singh(University of Alabama at Birmingham), Kenneth G. Saag(University of Alabama at Birmingham), Joel M. Kremer(Research Foundation for the State University of New York), Nivedita M. Patkar(University of Alabama at Birmingham), Elizabeth R. Volkmann(Boston Medical Center), W. Winn Chatham(University of Alabama at Birmingham), Charles M. King(North Mississippi Medical Center), Archana Jain(University of Alabama at Birmingham), Sangmee Bae(University of California, Los Angeles), Amye Leong(Healthy Start), Daniel E. Fürst(University of California, Los Angeles), Eric L. Matteson(Mayo Clinic), Timothy Beukelman(University of Alabama at Birmingham), Karen S. Kolba, John T. Schousboe(Park Nicollet Clinic), María E. Suarez‐Almazor(The University of Texas MD Anderson Cancer Center), Eileen Moynihan, Larry W. Moreland(University of Pittsburgh), Claire Bombardier(Toronto General Hospital), Dinesh Khanna(University of Michigan), Amy S. Mudano(University of Alabama at Birmingham), S. Louis Bridges(Hospital for Special Surgery), Harsh Agrawal(University of California, Los Angeles), Arthur F. Kavanaugh(University of California San Diego), Maxime Dougados(Délégation Paris 5), James R. O’Dell(University of Nebraska Medical Center), Aseem Bharat(University of Alabama at Birmingham), Jeffrey R. Curtis(University of Alabama at Birmingham Hospital), Harold E. Paulus(University of California, Los Angeles), Kevin Winthrop(Oregon Health & Science University)

Arthritis Care & Research

April 2, 2012

Cited by 1,799

|Arthritis & Rheumatism|1990|9.6k

|New England Journal of Medicine|2000|4k

|Journal of Clinical Oncology|2018|3.7k

|Arthritis & Rheumatology|2015|2.8k

|JAMA Oncology|2015|2.8k

Related Papers